Literature DB >> 20814659

Brachial plexopathy after chemoradiotherapy for head and neck squamous cell carcinoma.

Nele Platteaux1, Piet Dirix, Robert Hermans, Sandra Nuyts.   

Abstract

PURPOSE: To evaluate late brachial plexopathy after primary chemoradiotherapy for locally advanced head and neck squamous cell carcinoma. PATIENTS AND METHODS: Consecutive 43 disease-free patients were evaluated by a specifically developed 26-item questionnaire. Retrospectively, the brachial plexus was delineated and the dose-volume histograms were calculated.
RESULTS: After a median follow-up of 24 months, no radiation-induced brachial plexopathy was reported in these 43 patients.
CONCLUSION: No radiation-induced brachial plexopathy was seen in the patient group, although 72.1% of the brachial plexuses received doses > 60 Gy. These findings should prompt further prospective studies and also stress the importance of trying to keep the doses to the brachial plexus as low as possible while covering the target volumes well.

Entities:  

Mesh:

Year:  2010        PMID: 20814659     DOI: 10.1007/s00066-010-2099-0

Source DB:  PubMed          Journal:  Strahlenther Onkol        ISSN: 0179-7158            Impact factor:   3.621


  28 in total

1.  Chemotherapy added to locoregional treatment for head and neck squamous-cell carcinoma: three meta-analyses of updated individual data. MACH-NC Collaborative Group. Meta-Analysis of Chemotherapy on Head and Neck Cancer.

Authors:  J P Pignon; J Bourhis; C Domenge; L Designé
Journal:  Lancet       Date:  2000-03-18       Impact factor: 79.321

2.  Radiation-induced brachial plexopathy: MR and clinical findings.

Authors:  B C Bowen; A Verma; A H Brandon; J A Fiedler
Journal:  AJNR Am J Neuroradiol       Date:  1996 Nov-Dec       Impact factor: 3.825

3.  MR imaging of nontraumatic brachial plexopathies: frequency and spectrum of findings.

Authors:  K H Wittenberg; M C Adkins
Journal:  Radiographics       Date:  2000 Jul-Aug       Impact factor: 5.333

4.  Long-term radiation complications following conservative surgery (CS) and radiation therapy (RT) in patients with early stage breast cancer.

Authors:  S M Pierce; A Recht; T I Lingos; A Abner; F Vicini; B Silver; A Herzog; J R Harris
Journal:  Int J Radiat Oncol Biol Phys       Date:  1992       Impact factor: 7.038

5.  Simultaneous integrated boost (SIB) for nasopharynx cancer with helical tomotherapy. A planning study.

Authors:  Claudio Fiorino; Italo Dell'Oca; Alessio Pierelli; Sara Broggi; Giovanni Mauro Cattaneo; Anna Chiara; Elena De Martin; Nadia Di Muzio; Ferruccio Fazio; Riccardo Calandrino
Journal:  Strahlenther Onkol       Date:  2007-09       Impact factor: 3.621

6.  Longitudinal assessment of parotid function in patients receiving tomotherapy for head-and-neck cancer.

Authors:  Mia Voordeckers; Hendrik Everaert; Koen Tournel; Dirk Verellen; Ilan Baron; Gretel Van Esch; Chris Vanhove; Guy Storme
Journal:  Strahlenther Onkol       Date:  2008-08       Impact factor: 3.621

7.  Combined cetuximab and reirradiation for locoregional recurrent and inoperable squamous cell carcinoma of the head and neck.

Authors:  Panagiotis Balermpas; Markus Hambek; Oliver Seitz; Claus Rödel; Christian Weiss
Journal:  Strahlenther Onkol       Date:  2009-12       Impact factor: 3.621

8.  Impact of adding concomitant chemotherapy to hyperfractionated accelerated radiotherapy for advanced head-and-neck squamous cell carcinoma.

Authors:  Sandra Nuyts; Piet Dirix; Paul M J Clement; Vincent Vander Poorten; Pierre Delaere; Joseph Schoenaers; Robert Hermans; Walter Van den Bogaert
Journal:  Int J Radiat Oncol Biol Phys       Date:  2008-08-15       Impact factor: 7.038

9.  A patient questionnaire for radiation-induced brachial plexopathy.

Authors:  Ulrike Hoeller; Karin Rolofs; Amira Bajrovic; Juergen Berger; Christof Heesen; Gustav Pfeiffer; Winfried Alberti
Journal:  Am J Clin Oncol       Date:  2004-02       Impact factor: 2.339

10.  Chemoradiotherapy with weekly cisplatin 40 mg/m(2) in 103 head-and-neck cancer patients: a cumulative dose-effect analysis.

Authors:  Diana Steinmann; Bettina Cerny; Johann Hinrich Karstens; Michael Bremer
Journal:  Strahlenther Onkol       Date:  2009-10-06       Impact factor: 3.621

View more
  11 in total

1.  Prognostic factors (including HPV status) for irradiation of locally advanced squamous cell carcinoma of the head and neck (SCCHN).

Authors:  Dirk Rades; Nina D Seibold; Maximilian P Gebhard; Frank Noack; Steven E Schild; Christoph Thorns
Journal:  Strahlenther Onkol       Date:  2011-09-19       Impact factor: 3.621

Review 2.  Organ-sparing radiation therapy for head and neck cancer.

Authors:  XiaoShen Wang; ChaoSu Hu; Avraham Eisbruch
Journal:  Nat Rev Clin Oncol       Date:  2011-07-26       Impact factor: 66.675

3.  Reliability and accuracy assessment of Radiation Therapy Oncology Group-endorsed guidelines for brachial plexus contouring.

Authors:  Joris Van de Velde; Tom Vercauteren; Werner De Gersem; Johan Wouters; Katrien Vandecasteele; Philippe Vuye; Frank Vanpachtenbeke; Katharina D'Herde; Ingrid Kerckaert; Wilfried De Neve; Tom Van Hoof
Journal:  Strahlenther Onkol       Date:  2014-04-09       Impact factor: 3.621

4.  Prospective study on the dose distribution to the acoustic structures during postoperative 3D conformal radiotherapy for parotid tumors: dosimetric and audiometric aspects.

Authors:  Barbara A Jereczek-Fossa; Elena Rondi; Andrzej Zarowski; Alberto D'Onofrio; Daniela Alterio; Mario Ciocca; Livia Corinna Bianchi; Marco Krengli; Luca Calabrese; Mohssen Ansarin; Gioacchino Giugliano; Roberto Orecchia
Journal:  Strahlenther Onkol       Date:  2011-05-16       Impact factor: 3.621

5.  Cystatin C - a fast and reliable biomarker for glomerular filtration rate in head and neck cancer patients.

Authors:  Edwin Bölke; Gisela Schieren; Stephan Gripp; Gerald Steinbach; Matthias Peiper; Klaus Orth; Christiane Matuschek; Maximilian Pelzer; Guido Lammering; Ruud Houben; Christina Antke; Lars Christian Rump; Rodrigo Mota; Peter Arne Gerber; Patrick Schuler; Thomas K Hoffmann; Ethelyn Rusnak; Derik Hermsen; Wilfried Budach
Journal:  Strahlenther Onkol       Date:  2011-02-24       Impact factor: 3.621

6.  Comparison of radiochemotherapy alone to surgery plus radio(chemo)therapy for non-metastatic stage III/IV squamous cell carcinoma of the head and neck: A matched-pair analysis.

Authors:  Dirk Rades; Thekla Meyners; Nadja Kazic; Amira Bajrovic; Volker Rudat; Steven E Schild
Journal:  Strahlenther Onkol       Date:  2011-08-16       Impact factor: 3.621

7.  Brachial plexus dose tolerance in head and neck cancer patients treated with sequential intensity modulated radiation therapy.

Authors:  Tarita O Thomas; Tamer Refaat; Mehee Choi; Ian Bacchus; Sean Sachdev; Alfred W Rademaker; Vythialingam Sathiaseelan; Achilles Karagianis; Bharat B Mittal
Journal:  Radiat Oncol       Date:  2015-04-18       Impact factor: 3.481

8.  Clinical observation of peripheral nerve injury in 2 patients with cancer after radiotherapy.

Authors:  Zhao-Hui Zhang; Li Liang; Ting-Zhen Jia; Shu-Lan Zhang; Mo-Pei Wang; Li-Wen Ma; Qiang Liu
Journal:  Contemp Oncol (Pozn)       Date:  2013-04-29

9.  Late term tolerance in head neck cancer patients irradiated in the IMRT era.

Authors:  Gabriela Studer; Claudia Linsenmeier; Oliver Riesterer; Yousef Najafi; Michelle Brown; Bita Yousefi; Marius Bredell; Gerhard Huber; Stephan Schmid; Stephan Studer; Roger Zwahlen; Tamara Rordorf; Christoph Glanzmann
Journal:  Radiat Oncol       Date:  2013-11-05       Impact factor: 3.481

10.  Early transient radiation-induced brachial plexopathy in locally advanced head and neck cancer.

Authors:  Evrim Metcalfe; Durmus Etiz
Journal:  Contemp Oncol (Pozn)       Date:  2016-03-16
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.